777 related articles for article (PubMed ID: 25668264)
1. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A
JAMA; 2015 Feb; 313(6):603-15. PubMed ID: 25668264
[TBL] [Abstract][Full Text] [Related]
2. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
[TBL] [Abstract][Full Text] [Related]
4. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
Wang J; Chen Y; Xu W; Lu N; Cao J; Yu S
PLoS One; 2019; 14(4):e0215362. PubMed ID: 30978254
[TBL] [Abstract][Full Text] [Related]
5. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
Brunström M; Carlberg B
JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
[TBL] [Abstract][Full Text] [Related]
6. Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular outcomes in patients with diabetes when initiating blood pressure lowering at baseline SBP between 130 and 140 mm Hg: A meta-analysis.
Wang S; Djama NM; Lai Y; Li H; Liao W; Liao Y; Bin J
J Clin Hypertens (Greenwich); 2019 Feb; 21(2):220-229. PubMed ID: 30637947
[TBL] [Abstract][Full Text] [Related]
9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
11. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
Lancet Diabetes Endocrinol; 2022 Sep; 10(9):645-654. PubMed ID: 35878651
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure targets for hypertension in older adults.
Garrison SR; Kolber MR; Korownyk CS; McCracken RK; Heran BS; Allan GM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011575. PubMed ID: 28787537
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
15. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
Lv J; Neal B; Ehteshami P; Ninomiya T; Woodward M; Rodgers A; Wang H; MacMahon S; Turnbull F; Hillis G; Chalmers J; Perkovic V
PLoS Med; 2012; 9(8):e1001293. PubMed ID: 22927798
[TBL] [Abstract][Full Text] [Related]
16. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.
Brunström M; Carlberg B
BMJ; 2016 Feb; 352():i717. PubMed ID: 26920333
[TBL] [Abstract][Full Text] [Related]
17. Treatment blood pressure targets for hypertension.
Arguedas JA; Perez MI; Wright JM
Cochrane Database Syst Rev; 2009 Jul; (3):CD004349. PubMed ID: 19588353
[TBL] [Abstract][Full Text] [Related]
18. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
19. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies.
Zhang Y; Liang M; Sun C; Qu G; Shi T; Min M; Wu Y; Sun Y
J Hum Hypertens; 2019 Sep; 33(9):648-657. PubMed ID: 31363149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
